Recombinant IGFBP5 Protein, Human (His Tag) Recombinant Proteins The human IGFBP5 (NP_000590.1 ) (Met1-Glu272) was expressed with a polyhistidine tag at the C-terminus The recombinant human IGFBP5 consists of 263a.a and predicts a molecular weight of 30 kDa.
$ $99 In stock
Formulation: The recombinant human IGFBP5 consists of 263a.a and predicts a molecular weight of 30 kDa.
Source: Baculovirus-Insect Cells
Usage: Our products are for research use only. This product is not intended or approved for human, diagnostics or veterinary use

Recombinant IGFBP5 Protein, Human (His Tag)

Formulation: Recombinant IGFBP5 Protein was lyophilized from sterile 20 mM Tris, pH 8.0, 300 mM NaCl, 10 % glycerol.1

Source: Baculovirus-Insect Cells

Product Name Recombinant IGFBP5 Protein, Human (His Tag)
Product Type Recombinant Protein
Source Baculovirus-Insect Cells
Formulation Recombinant IGFBP5 Protein was lyophilized from sterile 20 mM Tris, pH 8.0, 300 mM NaCl, 10 % glycerol.1
Molecular Weight The recombinant human IGFBP5 consists of 263a.a and predicts a molecular weight of 30 kDa.
Endotoxin < 1.0 EU per μg protein as determined by the LAL method
Purity Greater than 95% as determined by SDS-PAGE.
Description The human IGFBP5 (NP_000590.1 ) (Met1-Glu272) was expressed with a polyhistidine tag at the C-terminus
Host Species Homo sapiens (Human)
Usage Our products are for research use only. This product is not intended or approved for human, diagnostics or veterinary use
Storage Store recombinant protein under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
AA Sequence Met1-Glu272
Memo IBP5 Protein, Human
Terminal Leu 21
Bioactivity Measured by its ability to inhibit the biological activity of IGF­I or IGF­II on MCF­7 human breast cancer cells. The ED50 for this effect is 0.1­0.5 µg/mL in the presence of 14 ng/mL rhIGF­II.